The Pharmaceutical Group of the European Union (PGEU) has published guidelines

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.326, 2001-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmaceutical biotechnology products approved within the European Union

By Walsh G.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 55, Iss. 1, 2003-01 ,pp. : 3-10

Elsevier

Access to resources Recommend Favorite

EFPIA workshop: the 2001 review of European Union pharmaceutical legislation

By Donna E.   Elena M.  

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 3, 2001-06 ,pp. : 145-149

Adis International

Access to resources Recommend Favorite

An Overview of the European Union's New Medicines Legislation: Implications for the Pharmaceutical Industry

By Jackman Margaret   Woods Kent  

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 4, 2006-01 ,pp. : 251-261

Adis International

Access to resources Recommend Favorite

Single European Currency and Monetary Union: Macroeconomic Implications for Pharmaceutical Spending

By Kanavos P.  

PharmacoEconomics, Vol. 13, Iss. 1 Part 2, 1998-01 ,pp. : 9-20

Adis International

Access to resources Recommend Favorite

Rabeprazole [`Pariet'] has been approved in a new indication in the European Union

By  

Inpharma, Vol. 1, Iss. 1264, 2000-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite